Artificial intelligence services

Global AI. Local intelligence.

Put the right AI in all the right places. With our worldwide reach and local intelligence, you’ll get the best insights, tech and action plan—translated across regions, regulations and cultures. Discover advantages, across markets—and redefine your potential. 

Our market planning and AI consulting services include:

• AI-readiness assessments
• Real-world AI simulations
• Organisational change management
• AI training across your business
• Data and analytics consulting
• AI development solutions 
• Governance models (centralised and federated)
• Regulatory compliance (global and local)

AI that scales smart and stays secure

We build AI with purpose. To protect your data. Adapt to threats. Evolve with your business. Through our open ecosystem of leading AI collaborators, we use the right AI models to integrate seamlessly with your operations, culture and technologies. 

Our AI consultancy build services cover:

• Access the latest AI tech, such as PwC agent OS
• Customised AI-model selection 
• Data optimisation and maintenance
• Technical integration and cloud modernisation
• Scalable, reusable AI patterns
• AI implementation across workflows and applications
• Integrated artificial-intelligence technology solutions

From blueprint to breakthrough

With fast-moving tech comes great responsibility. That’s why we design, build and manage your AI with a commitment to rigorous security, ethics and compliance across your value chain. Our approach enables your AI solutions to meet immediate needs while adapting to future requirements. The result? Technology that advances your business with confidence.

Our responsible AI methodology includes:

• Business case development
• Full strategy assessment and creation
• End-to-end implementation
• Responsible AI principles, controls and governance at every step—from ethics to privacy

AI that delivers

Deliver impact you can measure and sustain. Our AI solutions are built to achieve results—managing entire business functions and running core processes efficiently and effectively. We don’t just optimise operations. We transform them. The difference? Measurable outcomes today. Lasting competitive advantage.

Our AI transformation services include:

• Industry-specific AI solutions
• Business-driven transformation
• AI due diligence
• Functional transformation
• Process optimisation and ongoing management

AI flood resilience tool

Floods have displaced 24 million people and caused US$453 billion in damages in the past decade.

PwC Middle East’s AI-driven flood resilience tool uses geospatial AI to create dynamic, real-time simulations of potential flooding scenarios, incorporating data on topography, rainfall, cyclones and proximity to the ocean.

The 3D visualisations make it easy to understand the likely flow of the flood—helping government agencies, emergency services, insurance companies and homeowners mitigate loss and harm for the future.

AI model to guide interventions

The unpredictability and urgency of refugee movements make it difficult for public authorities to cope, balancing costs and local community impact.

PwC Netherlands developed a powerful AI model that uses data, community research and expert knowledge to provide authorities with quantitative insights into potential interventions—from education to employment, sports to transport.

Originally designed to support Ukrainian refugees, it outperforms human strategies. And the model can be easily adapted by decision-makers and NGOs anywhere—to improve trust and support with data-driven approaches.

Accelerating vital treatments with AI

Clinical trials can take up to 10–15 years and cost billions of dollars, greatly hampering the delivery of new treatments.

PwC US has been working with a leading pharma company to improve the process. With alliance partners AWS and Microsoft, PwC US used data analytics and GenAI to design a new clinical trial and integrated tech platform.

The results were significant: costs were reduced, the findings were more precise, time was cut by 20–25% and revenue increased by more than US$100 million. This approach could revolutionise a wide range of drug trials, benefiting patients and accelerating treatments.